“We will try using our administrative support capabilities to conduct all processes in a very organized manner as soon as possible,” RIA Novosti quotes Skvortsov.
It is noted that the Ministry of Health cannot register the drug without a manufacturer’s statement.
Earlier, Skvortsova said that the Moscow endocrine plant purchased about 10 thousand packages of the Frizium drug, which was not registered in Russia.